190 related articles for article (PubMed ID: 35276465)
41. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
42. Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
Umegaki K; Taki Y; Endoh K; Taku K; Tanabe H; Shinozuka K; Sugiyama T
J Pharm Pharmacol; 2007 Jun; 59(6):871-7. PubMed ID: 17637180
[TBL] [Abstract][Full Text] [Related]
43. Thermal fixation technologies affect phenolic profile, ginkgolides, bilobalide, product quality, and ginkgolic acids in Ginkgo biloba leaf tea.
Soetanto DA; Li F; Boateng ID; Yang XM
J Food Sci; 2024 Jul; 89(7):4093-4108. PubMed ID: 38783591
[TBL] [Abstract][Full Text] [Related]
44. Age-related changes in the vasodilating actions of Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.
Nishida S; Satoh H
Clin Chim Acta; 2005 Apr; 354(1-2):141-6. PubMed ID: 15748610
[TBL] [Abstract][Full Text] [Related]
45. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
van Beek TA; Montoro P
J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661
[TBL] [Abstract][Full Text] [Related]
46. Induction of heme oxygenase-1 by Ginkgo biloba extract but not its terpenoids partially mediated its protective effect against lysophosphatidylcholine-induced damage.
Chen JX; Zeng H; Chen X; Su CY; Lai CC
Pharmacol Res; 2001 Jan; 43(1):63-9. PubMed ID: 11207067
[TBL] [Abstract][Full Text] [Related]
47. Long-term feeding of Ginkgo biloba extract impairs peripheral circulation and hepatic function in aged spontaneously hypertensive rats.
Tada Y; Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Biol Pharm Bull; 2008 Jan; 31(1):68-72. PubMed ID: 18175944
[TBL] [Abstract][Full Text] [Related]
48. A method for extraction and quantification of Ginkgo terpene trilactones.
Ding C; Chen E; Zhou W; Lindsay RC
Anal Chem; 2004 Aug; 76(15):4332-6. PubMed ID: 15283569
[TBL] [Abstract][Full Text] [Related]
49. Effects of Ginkgo biloba extract feeding on salt-induced hypertensive Dahl rats.
Kubota Y; Tanaka N; Kagota S; Nakamura K; Kunitomo M; Umegaki K; Shinozuka K
Biol Pharm Bull; 2006 Feb; 29(2):266-9. PubMed ID: 16462029
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
[TBL] [Abstract][Full Text] [Related]
51. Validation of capillary gas chromatographic method for determination of bilobalide and ginkgolides A, B, C in Ginkgo biloba dry and liquid extracts.
Krzek J; Czekaj JS; Rzeszutko W; Ekiert RJ
Acta Pol Pharm; 2007; 64(4):303-10. PubMed ID: 18536155
[TBL] [Abstract][Full Text] [Related]
52. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
Biber A; Koch E
Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
[TBL] [Abstract][Full Text] [Related]
53. Effects of Ginkgo biloba extract on blood pressure and vascular endothelial response by acetylcholine in spontaneously hypertensive rats.
Kubota Y; Tanaka N; Kagota S; Nakamura K; Kunitomo M; Umegaki K; Shinozuka K
J Pharm Pharmacol; 2006 Feb; 58(2):243-9. PubMed ID: 16451753
[TBL] [Abstract][Full Text] [Related]
54. Screening and Identifying Antioxidative Components in Ginkgo biloba Pollen by DPPH-HPLC-PAD Coupled with HPLC-ESI-MS2.
Qiu J; Chen X; Netrusov AI; Zhou Q; Guo D; Liu X; He H; Xin X; Wang Y; Chen L
PLoS One; 2017; 12(1):e0170141. PubMed ID: 28095510
[TBL] [Abstract][Full Text] [Related]
55. The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review.
Feng Z; Sun Q; Chen W; Bai Y; Hu D; Xie X
Mol Med; 2019 Dec; 25(1):57. PubMed ID: 31864312
[TBL] [Abstract][Full Text] [Related]
56. Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-κB pathway in rats.
Li X; Huang L; Liu G; Fan W; Li B; Liu R; Wang Z; Fan Q; Xiao W; Li Y; Fang W
J Ethnopharmacol; 2020 Mar; 249():112365. PubMed ID: 31678414
[TBL] [Abstract][Full Text] [Related]
57. Ginkgolide A contributes to the potentiation of acetaminophen toxicity by Ginkgo biloba extract in primary cultures of rat hepatocytes.
Rajaraman G; Chen J; Chang TK
Toxicol Appl Pharmacol; 2006 Dec; 217(2):225-33. PubMed ID: 17045319
[TBL] [Abstract][Full Text] [Related]
58. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases.
Zhou W; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
Cardiovasc Drug Rev; 2004; 22(4):309-19. PubMed ID: 15592576
[TBL] [Abstract][Full Text] [Related]
59. Interaction of Ginkgo biloba extract (GBE) with hypotensive agent, nicardipine, in rats.
Kubota Y; Kobayashi K; Tanaka N; Nakamura K; Kunitomo M; Umegaki K; Shinozuka K
In Vivo; 2003; 17(5):409-12. PubMed ID: 14598602
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents.
Ahlemeyer B; Möwes A; Krieglstein J
Eur J Pharmacol; 1999 Feb; 367(2-3):423-30. PubMed ID: 10079019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
